Zhang Qingsong, Liang Fang, Ke Yang, Huo Yanping, Li Mingchuang, Li Yanyan, Yue Junmin
Department of Breast Surgery, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan 450007, P.R. China.
Department of Oncology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan 450007, P.R. China.
Oncol Rep. 2015 Jul;34(1):258-64. doi: 10.3892/or.2015.4004. Epub 2015 May 22.
Neogenin has been documented as playing an important role in cancer development. Although an elevated expression of neogenin has been detected in human breast cancer, the role of neogenin in breast cancer cells is not clearly understood. In the present study, we investigated neogenin in breast cancer cell proliferation, migration and apoptosis. We found that neogenin overexpression markedly reduced the proliferation and migration of breast cancer cells (P<0.05). Neogenin overexpression resulted in a reduction in the apoptosis rate. Inhibition of neogenin expression by neogenin siRNA dramatically promoted the proliferation and migration of breast cancer cells, whereas it inhibited cell apoptosis. Furthermore, we found that BMP-2-induced phosphorylation of Smad1/5/8 which was inhibited by neogenin overexpression. The present study demonstrates that neogenin may be a tumor suppressor in breast cancer. Neogenin may serve as a potential diagnostic marker and therapeutic target for breast cancer.
新生成蛋白(Neogenin)已被证明在癌症发展中发挥重要作用。尽管在人类乳腺癌中已检测到新生成蛋白表达升高,但其在乳腺癌细胞中的作用尚不清楚。在本研究中,我们研究了新生成蛋白在乳腺癌细胞增殖、迁移和凋亡中的作用。我们发现新生成蛋白过表达显著降低了乳腺癌细胞的增殖和迁移(P<0.05)。新生成蛋白过表达导致凋亡率降低。新生成蛋白小干扰RNA(siRNA)抑制新生成蛋白表达显著促进了乳腺癌细胞的增殖和迁移,而抑制了细胞凋亡。此外,我们发现骨形态发生蛋白2(BMP-2)诱导的Smad1/5/8磷酸化被新生成蛋白过表达所抑制。本研究表明,新生成蛋白可能是乳腺癌中的一种肿瘤抑制因子。新生成蛋白可能作为乳腺癌的潜在诊断标志物和治疗靶点。